Literature DB >> 21079996

Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

Lu Jiang1, Yang Dai, Xiqiang Liu, Cheng Wang, Anxun Wang, Zujian Chen, Caroline E Heidbreder, Antonia Kolokythas, Xiaofeng Zhou.   

Abstract

MicroRNA deregulation is a critical event in tumor initiation and progression. The down-regulation of microRNA-138 has been frequently observed in various cancers, including tongue squamous cell carcinoma (TSCC). Our previous studies suggest that deregulation of miR-138 is associated with the enhanced proliferation and invasion in TSCC cells. Here, we seek to identify the targets of miR-138 in TSCC, and explore their functional relevance in tumorigenesis. Our genome-wide expression profiling experiments identified a panel of 194 unique transcripts that were significantly down-regulated in TSCC cells transfected with miR-138. A comprehensive screening using six different sequence-based microRNA target prediction algorithms revealed that 51 out of these 194 down-regulated transcripts are potential direct targets for miR-138. These targets include: chloride channel, nucleotide-sensitive, 1A (CLNS1A), G protein alpha inhibiting activity polypeptide 2 (GNAI2), solute carrier family 20, member 1 (SLC20A1), eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), and Rho-related GTP-binding protein C (RhoC). GNAI2 is a known proto-oncogene that is involved in the initiation and progression of several different types of tumors. Direct targeting of miR-138 to two candidate binding sequences located in the 3'-untranslated region of GNAI2 mRNA was confirmed using luciferase reporter gene assays. Knockdown of miR-138 in TSCC cells enhanced the expression of GNAI2 at both mRNA and protein levels. In contrast, ectopic transfection of miR-138 reduced the expression of GNAI2, which, in consequence, led to reduced proliferation, cell cycle arrest and apoptosis. In summary, we identified a number of high-confident miR-138 target genes, including proto-oncogene GNAI2, which may play an important role in TSCC initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079996      PMCID: PMC3121246          DOI: 10.1007/s00439-010-0915-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  55 in total

1.  Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i)

Authors:  N Mochizuki; Y Ohba; E Kiyokawa; T Kurata; T Murakami; T Ozaki; A Kitabatake; K Nagashima; M Matsuda
Journal:  Nature       Date:  1999-08-26       Impact factor: 49.962

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

4.  Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma.

Authors:  I H McKillop; Y Wu; P A Cahill; J V Sitzmann
Journal:  J Cell Physiol       Date:  1998-06       Impact factor: 6.384

5.  Possible mechanism of CCL2-induced Akt activation in prostate cancer cells.

Authors:  Kosuke Mizutani; Hernan Roca; Zachary Varsos; Kenneth J Pienta
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

6.  Inhibitory heterotrimeric GTP-binding proteins inhibit hydrogen peroxide-induced apoptosis by up-regulation of Bcl-2 via NF-kappaB in H1299 human lung cancer cells.

Authors:  Miran Seo; Hyo-Jung Nam; So-Young Kim; Yong-Sung Juhnn
Journal:  Biochem Biophys Res Commun       Date:  2009-02-20       Impact factor: 3.575

7.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

10.  A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

Authors:  Gabriele Siegel; Gregor Obernosterer; Roberto Fiore; Martin Oehmen; Silvia Bicker; Mette Christensen; Sharof Khudayberdiev; Philipp F Leuschner; Clara J L Busch; Christina Kane; Katja Hübel; Frank Dekker; Christian Hedberg; Balamurugan Rengarajan; Carsten Drepper; Herbert Waldmann; Sakari Kauppinen; Michael E Greenberg; Andreas Draguhn; Marc Rehmsmeier; Javier Martinez; Gerhard M Schratt
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

View more
  38 in total

1.  Low expression of GNAI3 predicts poor prognosis in patients with HCC.

Authors:  Guodong Chen; Xiaoyan Li; Gengsheng He; Zijian Yu; Jiaxing Luo; Jun He; Zonghai Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.

Authors:  Xiaozhen Wu; Zuode Gong; Lanying Sun; Long Ma; Qibao Wang
Journal:  Cell Prolif       Date:  2017-03-20       Impact factor: 6.831

3.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.

Authors:  Zujian Chen; Yi Jin; Dongsheng Yu; Anxun Wang; Ishrat Mahjabeen; Cheng Wang; Xiqiang Liu; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2012-03-17       Impact factor: 5.337

Review 4.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

5.  Gene expression of miRNA-138 and cyclin D1 in oral lichen planus.

Authors:  Noha A Ghallab; Rehab Fawzy Kasem; Safa Fathy Abd El-Ghani; Olfat G Shaker
Journal:  Clin Oral Investig       Date:  2017-03-08       Impact factor: 3.573

6.  Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.

Authors:  Mohammad Iqbal Rather; Mathighatta N Nagashri; Shivananda S Swamy; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

7.  Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma.

Authors:  Yi Jin; Cheng Wang; Xiqiang Liu; Wenbo Mu; Zujian Chen; Dongsheng Yu; Anxun Wang; Yang Dai; Xiaofeng Zhou
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

Review 8.  Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.

Authors:  Yi Jin; Dan Chen; Robert J Cabay; Anxun Wang; David L Crowe; Xiaofeng Zhou
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

9.  MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells.

Authors:  J S Huang; M E Egger; W E Grizzle; L R McNally
Journal:  Biotech Histochem       Date:  2013-02-04       Impact factor: 1.718

10.  Evaluating the microRNA targeting sites by luciferase reporter gene assay.

Authors:  Yi Jin; Zujian Chen; Xiqiang Liu; Xiaofeng Zhou
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.